BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34088823)

  • 1. Multilevel Small Area Estimation of Prostate-Specific Antigen Screening Test in the United States by Age Group: 2018 Behavioral Risk Factor Surveillance System.
    Berkowitz Z; Zhang X; Richards TB; Sabatino SA; Peipins LA; Smith JL
    J Am Board Fam Med; 2021; 34(3):634-647. PubMed ID: 34088823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association of County-level Prostate-specific Antigen Screening with Metastatic Prostate Cancer and Prostate Cancer Mortality.
    Stone BV; Labban M; Beatrici E; Filipas DK; D'Amico AV; Lipsitz SR; Choueiri TK; Kibel AS; Cole AP; Iyer HS; Trinh QD
    Eur Urol Oncol; 2024 Jun; 7(3):563-569. PubMed ID: 38155059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multilevel Small-Area Estimation of Colorectal Cancer Screening in the United States.
    Berkowitz Z; Zhang X; Richards TB; Nadel M; Peipins LA; Holt J
    Cancer Epidemiol Biomarkers Prev; 2018 Mar; 27(3):245-253. PubMed ID: 29500250
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW
    JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to Prostate-Specific Antigen Testing and Mortality Among Men With Prostate Cancer.
    Iyer HS; Stone BV; Roscoe C; Hsieh MC; Stroup AM; Wiggins CL; Schumacher FR; Gomez SL; Rebbeck TR; Trinh QD
    JAMA Netw Open; 2024 Jun; 7(6):e2414582. PubMed ID: 38833252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the prostate-specific antigen test among men aged 75 years or older in the United States: 2006 Behavioral Risk Factor Surveillance System.
    Li J; Zhao G; Pollack LA; Smith JL; Joseph DA
    Prev Chronic Dis; 2010 Jul; 7(4):A84. PubMed ID: 20550842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of health literacy on shared decision making for prostate-specific antigen screening in the United States.
    Nguyen DD; Trinh QD; Cole AP; Kilbridge KL; Mahal BA; Hayn M; Hansen M; Han PKJ; Sammon JD
    Cancer; 2021 Jan; 127(2):249-256. PubMed ID: 33165954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific antigen testing in older men in the USA: data from the behavioral risk factor surveillance system.
    Scosyrev E; Wu G; Golijanin D; Messing E
    BJU Int; 2012 Nov; 110(10):1485-90. PubMed ID: 22448649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?
    Sirovich BE; Schwartz LM; Woloshin S
    JAMA; 2003 Mar; 289(11):1414-20. PubMed ID: 12636464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.
    Jemal A; Fedewa SA; Ma J; Siegel R; Lin CC; Brawley O; Ward EM
    JAMA; 2015 Nov; 314(19):2054-61. PubMed ID: 26575061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.
    Drazer MW; Huo D; Eggener SE
    J Clin Oncol; 2015 Aug; 33(22):2416-23. PubMed ID: 26056181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multilevel small area estimation for county-level prevalence of colorectal cancer screening test use in the United States using 2018 data.
    Berkowitz Z; Zhang X; Richards TB; Sabatino SA; Smith JL; Peipins LA; Nadel M
    Ann Epidemiol; 2022 Feb; 66():20-27. PubMed ID: 34718132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State-by-state Variation in Prostate-specific Antigen Screening Trends Following the 2011 United States Preventive Services Task Force Panel Update.
    Vetterlein MW; Dalela D; Sammon JD; Karabon P; Sood A; Jindal T; Meyer CP; Löppenberg B; Sun M; Trinh QD; Menon M; Abdollah F
    Urology; 2018 Feb; 112():56-65. PubMed ID: 29056579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient perspectives of prostate cancer screening vary by race following 2018 guideline changes.
    Riviere P; Kalavacherla S; Banegas MP; Javier-Desloges J; Martinez ME; Garraway IP; Murphy JD; Rose BS
    Cancer; 2023 Jan; 129(1):82-88. PubMed ID: 36345568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer-Specific Mortality.
    Burgess L; Aldrighetti CM; Ghosh A; Niemierko A; Chino F; Huynh MJ; Efstathiou JA; Kamran SC
    JAMA Netw Open; 2022 May; 5(5):e2211869. PubMed ID: 35576008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Prostate-specific Antigen Screening after the 2018 United States Preventive Services Task Force Recommendations and Through the COVID-19 Pandemic.
    Qian Z; Chen X; Cole AP; Abdollah F; Choueiri TK; Kibel AS; Lipsitz SR; Iyer HS; Trinh QD
    Eur Urol Oncol; 2024 Feb; 7(1):151-154. PubMed ID: 37487814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States.
    Mahal BA; Chen YW; Muralidhar V; Mahal AR; Choueiri TK; Hoffman KE; Hu JC; Sweeney CJ; Yu JB; Feng FY; Kim SP; Beard CJ; Martin NE; Trinh QD; Nguyen PL
    Ann Oncol; 2017 May; 28(5):1098-1104. PubMed ID: 28453693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multilevel Small Area Estimation for County-Level Prevalence of Mammography Use in the United States Using 2018 Data.
    Berkowitz Z; Zhang X; Richards TB; Sabatino SA; Peipins LA; Smith JL
    J Womens Health (Larchmt); 2023 Feb; 32(2):216-223. PubMed ID: 36301186
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostate Cancer Screening Uptake in Transgender Women.
    Kalavacherla S; Riviere P; Kalavacherla S; Anger JT; Murphy JD; Rose BS
    JAMA Netw Open; 2024 Feb; 7(2):e2356088. PubMed ID: 38353948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.